Analyst Forecasts For Ovzon AB (publ) (STO:OVZON) Are Surging Higher

Simply Wall St

Ovzon AB (publ) (STO:OVZON) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's forecasts. Consensus estimates suggest investors could expect greatly increased statutory revenues and earnings per share, with analysts modelling a real improvement in business performance.

Following the upgrade, the current consensus from Ovzon's twin analysts is for revenues of kr781m in 2025 which - if met - would reflect a major 113% increase on its sales over the past 12 months. The losses are expected to disappear over the next year or so, with forecasts for a profit of kr0.84 per share this year. Before this latest update, the analysts had been forecasting revenues of kr638m and earnings per share (EPS) of kr0.53 in 2025. There has definitely been an improvement in perception recently, with the analysts substantially increasing both their earnings and revenue estimates.

See our latest analysis for Ovzon

OM:OVZON Earnings and Revenue Growth June 14th 2025

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Ovzon's past performance and to peers in the same industry. It's clear from the latest estimates that Ovzon's rate of growth is expected to accelerate meaningfully, with the forecast 173% annualised revenue growth to the end of 2025 noticeably faster than its historical growth of 14% p.a. over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 0.2% per year. Factoring in the forecast acceleration in revenue, it's pretty clear that Ovzon is expected to grow much faster than its industry.

The Bottom Line

The biggest takeaway for us from these new estimates is that analysts upgraded their earnings per share estimates, with improved earnings power expected for this year. Fortunately, analysts also upgraded their revenue estimates, and our data indicates sales are expected to perform better than the wider market. With a serious upgrade to expectations, it might be time to take another look at Ovzon.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. At least one analyst has provided forecasts out to 2027, which can be seen for free on our platform here.

Another way to search for interesting companies that could be reaching an inflection point is to track whether management are buying or selling, with our free list of growing companies backed by insiders.

Valuation is complex, but we're here to simplify it.

Discover if Ovzon might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.